Patent Assignment
Reel/Frame 063397/0450
Change of Name
Recorded: 2023-04-20
Pages: 11
Assignor
RUN X CORPORATION
Executed: 2022-07-26
Assignee
GENECRAFT INC.
CHUNGBUK UNIVERSITY, RM 480 E9, CHUNGDAE-RO 1, SEOWON-GU, CHUNGCHEONGBUK-DO, CHUNGJU-SI, 28644, KOREA, REPUBLIC OF
Covered Property
(1)
PHARMACEUTICAL COMPOSITION COMPRISING RUNX3 PROTEIN AND CDK4 INHIBITOR OR mTOR INHIBITOR COTREATMENT FOR PREVENTION OR TREATMENT OF CANCER
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.